Med-Chemist : "Quintessential Medicinal Chemistry"
Monday, August 8, 2011
FDA Accepts NDA Filing for Ruxolitinib as a Treatment for Myelofibrosis
FDA Accepts NDA Filing for Ruxolitinib as a Treatment for Myelofibrosis
No comments:
Post a Comment
‹
›
Home
View web version
No comments:
Post a Comment